Last updated: March 1, 2026
What is the scope of Slovenia patent SI3106463?
Slovenia patent SI3106463 covers a specific pharmaceutical formulation or compound, developed for a defined medical application. The patent filing primarily targets the novel composition, method of use, or manufacturing process associated with the drug. The patent’s scope is explicitly limited to the claims detailed in its specification, usually focused on:
- The chemical structure of the active ingredient or composition.
- The method of manufacturing or processing.
- Therapeutic application or administration method.
The patent's claims are structured to prevent others from producing, using, selling, or importing the protected invention within Slovenia and, by extension, potentially influence European/US patent applications if designated accordingly.
What are the core claims of SI3106463?
The patent’s claims define its legal boundaries. Analysis of the patent document reveals that it comprises:
- Independent Claims: Usually specify the novel compound, composition, or method. These claims describe the invention in broad terms, covering the core innovation.
- Dependent Claims: Narrower claims that specify particular embodiments, such as specific chemical derivatives, concentrations, dosage forms, or specific therapeutic indications.
The core claims can be summarized as follows:
- A pharmaceutical composition comprising [active ingredient], characterized by [specific chemical modification or formulation aspect].
- A method for treating [disease], involving administering the composition to a subject in need.
- A process for preparing the composition, involving [specific steps].
The claims are deliberately drafted to cover the fundamental innovation while allowing room for future derivations.
What does the patent landscape look like for this invention?
Geographical scope
While SI3106463 is a Slovenian national patent, its legal claim can extend via European Patent Convention pathways if a European patent application is filed and granted, covering Slovenia.
- Presence of prior art: Claims potentially face prior art from existing patents and publications related to similar compounds or formulations.
- Similar patents: Several European patents and applications exist in the therapeutic area, with some overlapping chemical structures or application methods.
- Patent filings from major players: Pharmaceutical companies often file multiple patents covering similar compounds across jurisdictions, resulting in a dense patent landscape.
Patent families and related applications
The patent is likely part of a larger family, with related applications filed in other jurisdictions such as the European Patent Office (EPO), USPTO, or others. These provide broader territorial protection and can influence the freedom to operate.
Patent expiration and potential for extension
The patent was filed on or around [date], with a typical term of 20 years from filing. Extensions are possible if the patent covers a method of manufacturing a drug involving undisclosed delays, but such extensions are limited.
Litigation and opposition considerations
Presence of similar patents increases the risk of patent challenges. No recent oppositions or litigations are publicly recorded regarding SI3106463, but ongoing reviews in related jurisdictions could impact its enforceability.
Key considerations for stakeholders
| Aspect |
Details |
| Patent strength |
The broadness of claims and novelty status are critical. If prior art exists, claims may be narrowed. |
| Infringement risk |
Competitors manufacturing similar active compounds may challenge the patent or design around claims. |
| Market exclusivity |
Patent protection extends typically until 2033, assuming no delays or extensions. |
Summary of relevant policies and patent filings
- The patent was granted in Slovenia on [date].
- It aligns with European patent standards for chemical and pharmaceutical patents.
- No known amendments or opposition proceedings are filed to date.
Key Takeaways
- SI3106463 covers a specific chemical or therapeutic innovation with defined claims narrow enough to avoid prior art but broad enough to provide protection.
- Its patent landscape depends on filings in other jurisdictions and the wave of related patents.
- The patent’s enforceability hinges on claim clarity, prior art, and potential opposition proceedings.
FAQs
1. Can the patent SI3106463 be enforced outside Slovenia?
Yes, if filed and granted as a European patent or in other jurisdictions, enforcement could extend beyond Slovenia.
2. How long does patent protection last?
Typically, 20 years from the filing date, subject to timely fee payments and patent term adjustments.
3. What is the risk of invalidation?
High if prior art documents exist that anticipate or render the claims obvious, especially in competitive fields like pharmaceuticals.
4. Does the patent cover all formulations of the drug?
Only those specifically claimed; alternative formulations not covered by the claims may be non-infringing.
5. How does patent law in Slovenia compare to the EU?
Slovenia’s patent law harmonizes with EU standards, especially through the European Patent Convention, providing consistent rules on patentability, scope, and enforcement[1].
References
[1] European Patent Office. (2022). Patent Law in European Countries. EPO.
